Abstract Details

Title Leukoaraiosis is associated with impaired functional recovery and outcome after mild ischemic stroke.

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 153

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Sanjeeva R. Onteddu, MD, FAAN (UAMS) PRESENTER	Dr. Onteddu has nothing to disclose.
Artin Minaeian, MD (Artin Minaeian MD Inc)	No disclosure on file
Richard P. Goddeau, Jr., DO (UMass Medical Center)	No disclosure on file
Nils Henninger, MD, PhD, FANA, FWSO (UMass Memorial Medical Center)	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.
Jing Marantz	No disclosure on file

��ɫ����